Delivery Order SPE2DB20D3304-SPE2DB24FW6S0
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,840.94 firm-fixed-price delivery order is for the supply of 4,564,996,919 units of the drug Glipizide ER 5 mg tablets. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,806.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glipizide ER 5 mg Tablets in quantities of 1,000 tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 10, 2024. This award does not utilize any set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,396.23, is for the delivery of 4,567,909,357 tablets of Glipizide ER 5 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,776.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,936 units of the medication Glipizide ER 10 mg tablet, with a completion date of April 17, 2025. This contract is a delivery order, with a firm fixed-price pricing type, and is not a set-aside award. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award, valued at $25,226.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,389,606 tablets of the medication Glipizide ER 10 mg, a treatment for diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract...
This federal contract award is for $1,710.41 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for GLIPIZIDE ER 10 MG TABLET 500S, with a firm fixed price and an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,911.01 fixed-price contract is for the supply of Glipizide ER 10 mg tablets, a medication used to treat diabetes. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567294880 units of Glipizide ER 10 mg tablets. The contract has a ceiling value of $3,178.32 and a period of performance through February 19, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,514.11, is for the supply of 4566825852 - GLIPIZIDE ER 10 MG TABLET 500S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 3, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. In addition to...
This federal contract award, valued at $3,675.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, to provide GLIPIZIDE ER 10 MG TABLET 1000S to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...